Effects of the PAR-1 Antagonist Vorapaxar on Platelet Activation and Coagulation Biomarkers in Patients with Stable Coronary Artery Disease

Por Renske H. Olie, Paola E. J. van der Meijden, Henri M. H. Spronk, Rene van Oerle, Stale Barvik, Vernon V. S. Bonarjee, Hugo ten Cate, Dennis W. T. Nilsen
Publicado em 2019-07-01

Protein C or Protein S deficiency associates with paradoxically impaired platelet‐dependent thrombus and fibrin formation under flow

Por Sanne L. N. Brouns, Bibian M. E. Tullemans, Cristiana Bulato, Gina Perrella, Elena Campello, Luca Spiezia, Johanna P. vanGeffen, Marijke J. E. Kuijpers, René vanOerle, Henri M. H. Spronk, Paola E. J. van derMeijden, Paolo Simioni, Johan W. M. Heemskerk
Publicado em 2022-02-01